IMO thank you, this is helpful and is exciting when you see some of the results where there was substantial improvement with Leronlimab. Adding to that, if there is the possibility that the ones that provided less than placebo or equal benefit might be better with LL makes that even more encouraging.

Definitely seems like something CYDY can explore later down the road IMO.